MedPath

A Comparative study on the effect of Special Diet Hardeum Vulgare (Yava), Cicer Arietium (Chana) and Eleusin Coracana (Ragi) with Usual Diet in the control of Obesity

Phase 3
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2023/09/057629
Lead Sponsor
Department of Kayachikitsha, Faculty of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Respondents will be confined to age group of 21-60 year

2. Study will be done on obese patients from SSL Hospital BHU

3. Patient having clinical symptoms of obesity

Patient with the BMI >29.9 will be included in this study

4. Patient with WHR > 0.90 (men) and > 0.85 (women) will be included patient willing to trial

Exclusion Criteria

Patient below the age of 21 and above 60 will be excluded from study.

Patient with BMI <29.9 will be excluded from study

Patients with WHR < 0.90 (men) and < 0.85 (women) will be included patient who are not willing to trail

•Pregnant and lactating mother are excluded from study.

•Patient suffering from any severe systemic disease. (like renal failure, hepatic failure, cardiac failure, cancer, genetic and endocrinal disorder will be excluded from study)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypothesis <br/ ><br>There will be more significant of one group on the two groups on patient suffering from Obesity <br/ ><br>Null Hypothesis <br/ ><br>There will be no significant effect of Special diet & Usual diet for Obese patients <br/ ><br> <br/ ><br>Timepoint: 90 days study with followup every 30 days
Secondary Outcome Measures
NameTimeMethod
SUBJECTIVE-Excess body fat,Breathlessness, Weakness, Laziness, Polydipsia, Polyphagia <br/ ><br>OBJECTIVE- Height, Weight, BMI, WHR, Triceps & Biceps Skin fold Thickness , Abdominal skin fold thickness <br/ ><br>Diagnostic criteria- CBC, Lipid Parameter (Triglyceride), HDL, LDL, VLDL,Fasting Blood Glucose <br/ ><br>LFT, RFT, Thyroid <br/ ><br>Timepoint: 90 days & followup with every 30 days
© Copyright 2025. All Rights Reserved by MedPath